Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.

Bian Y, Shang S, Siddiqui S, Zhao J, Joosten SA, Ottenhoff THM, Cantor H, Wang CR.

PLoS Pathog. 2017 May 5;13(5):e1006384. doi: 10.1371/journal.ppat.1006384. eCollection 2017 May.

2.

Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection.

Shang S, Siddiqui S, Bian Y, Zhao J, Wang CR.

PLoS Pathog. 2016 Jun 7;12(6):e1005688. doi: 10.1371/journal.ppat.1005688. eCollection 2016 Jun.

3.

Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Joosten SA, van Meijgaarden KE, van Weeren PC, Kazi F, Geluk A, Savage ND, Drijfhout JW, Flower DR, Hanekom WA, Klein MR, Ottenhoff TH.

PLoS Pathog. 2010 Feb 26;6(2):e1000782. doi: 10.1371/journal.ppat.1000782.

4.

Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.

Caccamo N, Pietra G, Sullivan LC, Brooks AG, Prezzemolo T, La Manna MP, Di Liberto D, Joosten SA, van Meijgaarden KE, Di Carlo P, Titone L, Moretta L, Mingari MC, Ottenhoff TH, Dieli F.

Eur J Immunol. 2015 Apr;45(4):1069-81. doi: 10.1002/eji.201445193. Epub 2015 Feb 17. Erratum in: Eur J Immunol. 2019 Jun;49(6):971.

5.

The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.

Lohwasser S, Kubota A, Salcedo M, Lian RH, Takei F.

Int Immunol. 2001 Mar;13(3):321-7.

PMID:
11222501
6.

HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells.

Harriff MJ, Wolfe LM, Swarbrick G, Null M, Cansler ME, Canfield ET, Vogt T, Toren KG, Li W, Jackson M, Lewinsohn DA, Dobos KM, Lewinsohn DM.

Sci Rep. 2017 Jul 4;7(1):4622. doi: 10.1038/s41598-017-04894-0.

7.

A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.

Rai PK, Chodisetti SB, Maurya SK, Nadeem S, Zeng W, Janmeja AK, Jackson DC, Agrewala JN.

J Transl Med. 2018 Oct 11;16(1):279. doi: 10.1186/s12967-018-1653-x.

8.

Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells.

Prezzemolo T, van Meijgaarden KE, Franken KLMC, Caccamo N, Dieli F, Ottenhoff THM, Joosten SA.

Eur J Immunol. 2018 Feb;48(2):293-305. doi: 10.1002/eji.201747184. Epub 2017 Dec 15.

9.

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.

Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ, Flynn JL, Barnes PF, Southwood S, Celis E, Bloom BR, Modlin RL, Sette A.

Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12210-5.

10.

Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis.

Axelsson-Robertson R, Ju JH, Kim HY, Zumla A, Maeurer M.

Int J Infect Dis. 2015 Mar;32:13-22. doi: 10.1016/j.ijid.2014.12.017.

11.

Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.

De La Barrera SS, Finiasz M, Frias A, Alemán M, Barrionuevo P, Fink S, Franco MC, Abbate E, del C Sasiain M.

Clin Exp Immunol. 2003 Jun;132(3):450-61.

12.

Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.

van Meijgaarden KE, Haks MC, Caccamo N, Dieli F, Ottenhoff TH, Joosten SA.

PLoS Pathog. 2015 Mar 24;11(3):e1004671. doi: 10.1371/journal.ppat.1004671. eCollection 2015 Mar.

13.

Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction.

Lewinsohn DM, Briden AL, Reed SG, Grabstein KH, Alderson MR.

J Immunol. 2000 Jul 15;165(2):925-30.

14.

Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.

Tully G, Kortsik C, Höhn H, Zehbe I, Hitzler WE, Neukirch C, Freitag K, Kayser K, Maeurer MJ.

J Immunol. 2005 Feb 15;174(4):2174-84.

15.

Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Holderried TA, Lang PA, Kim HJ, Cantor H.

Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21089-94. doi: 10.1073/pnas.1320999110. Epub 2013 Dec 9.

16.

IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.

de la Barrera S, Aleman M, Musella R, Schierloh P, Pasquinelli V, Garcia V, Abbate E, Sasiain Mdel C.

Clin Exp Immunol. 2004 Oct;138(1):128-38.

17.

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.

Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N.

Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. eCollection 2014. Review.

18.

Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.

Commandeur S, Coppola M, Dijkman K, Friggen AH, van Meijgaarden KE, van den Eeden SJ, Wilson L, van der Ploeg-van Schip JJ, Franken KL, Geluk A, Ottenhoff TH.

PLoS One. 2014 Jun 6;9(6):e99203. doi: 10.1371/journal.pone.0099203. eCollection 2014.

19.

Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.

Lewinsohn DM, Zhu L, Madison VJ, Dillon DC, Fling SP, Reed SG, Grabstein KH, Alderson MR.

J Immunol. 2001 Jan 1;166(1):439-46.

20.

Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis.

Mir SA, Sharma S.

Vaccine. 2013 Aug 20;31(37):3818-25. doi: 10.1016/j.vaccine.2013.04.005. Epub 2013 Apr 28. Review.

PMID:
23628242

Supplemental Content

Support Center